Specialist Investment Awards finalist interview: Seneca's Steve Hunter

Catching up with this year's nominees

Investment Week
clock • 2 min read

Seneca Investment Managers made the shortlists for both the Boutique of the Year (under £1bn AUM) and Best Specialist Multi-Asset Group of the Year categories at this year's Investment Week Specialist Investment Awards.

Here, we talk to Steve Hunter, head of business development, about the evolution of Seneca Investment Managers and how the group has responded to the challenges of 2020.    Can you give a brief overview of the development of Seneca Investment Managers in recent years and what is important to you as a company?  Seneca IM has flourished as a boutique house in recent years and has seen a substantial increase in assets under management as a result. The key driver for this is being unique, and in being so we have been able to sit well within and complement investor portfolios, without th...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot